Arie Belldegrun's Net Worth
Estimate Recalculated Nov 11, 2024 01:52PM EST
Who is Arie Belldegrun
Arie Belldegrun has an estimated net worth of $6.86 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Cougar Biotechnology, Inc., Paramount Acquisition Corp, Kronos Bio, Inc., Ginkgo Bioworks Holdings, Inc., UroGen Pharma Ltd., Kite Pharma, Inc., Nile Therapeutics, Inc., Hana Biosciences Inc, and Arno Therapeutics, Inc.
SEC CIK
Arie Belldegrun's CIK is 0001296549
Past Insider Trading and Trends
2006 was Arie Belldegrun's most active year for acquiring shares with 10 total transactions. Arie Belldegrun's most active month to acquire stocks was the month of May. 2009 was Arie Belldegrun's most active year for disposing of shares, totalling 9 transactions. Arie Belldegrun's most active month to dispose stocks was the month of June. 2021 saw Arie Belldegrun paying a total of $6,938,992.52 for 669,006 shares, this is the most they've acquired in one year. In 2017 Arie Belldegrun cashed out on 585,107 shares for a total of $22,103,372.18, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
